Dostarlimab plus chemotherapy is the only immuno-oncology combination to show statistically significant and clinically meaningful overall survival (OS) in the
Read more
Astellas Pharma recently announced results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for enfortumab vedotin in
Read more
The International Canoe Federation’s (ICF) Women’s Paddlesports Symposium, hosted by Canoeing Ireland concluded with participants from 34 countries agreeing to actions
Read more
Talquetamab, the first bispecific antibody targeting GPRC5D, showed an overall response rate of more than 70 percent with durable responses,
Read more
Approval for AKEEGA® is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision medicine study that includes the largest cohort to
Read more
Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets. Full prescribing information
Read more
Biopharmaceutical company AbbVie launches new schools’ prize to help spark an interest in STEM New initiative will be rolled out
Read more
Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced today that Erleada®▼(apalutamide) has been granted reimbursement in Ireland for the
Read more
Clonmel Healthcare is delighted to announce the launch of Pirfenidone Clonmel 267mg and 801mg film-coated tablets. Pirfenidone Clonmel is indicated
Read more
Upadacitinib is now approved by the European Commission for the treatment of adult patients with moderately to severely active ulcerative
Read more